CNBC February 3, 2025
Key Points
– President Donald Trump’s steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the U.S. and raise health-care costs for patients, some drug trade groups warn.
– They also said the import taxes could strain cash-strapped generic drugmakers and distributors.
– Trump on Saturday announced he would impose a 25% tariff on nearly all goods shipped from Canada and Mexico and a 10% charge on imports from China.
President Donald Trump‘s steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the U.S., raise health-care costs for patients and threaten cash-strapped generic drugmakers, some drug trade groups warn.
Trump on Saturday announced he would impose a 25% tariff on nearly...